Skip to main content

Sprycel: Dasatinib

Volume 454: debated on Wednesday 13 December 2006

To ask the Secretary of State for Health whether she intends to refer Sprycel (Dasatinib) to the National Institute for Health and Clinical Excellence for a health technology appraisal. (108507)

We currently have no plans to refer Sprycel (Dasatinib) to the National Institute for Health and Clinical Excellence for a health technology appraisal.